Cerebral Amyloid Angiopathy: Emerging Concepts
2
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
Cerebral amyloid angiopathy (CAA) involves cerebrovascular amyloid deposition and is classified into several types according to the amyloid protein involved. Of these, sporadic amyloid β-protein (Aβ)-type CAA is most commonly found in older individuals and in patients with Alzheimer’s disease (AD). Cerebrovascular Aβ deposits accompany functional and pathological changes in cerebral blood vessels (CAA-associated vasculopathies). CAA-associated vasculopathies lead to development of hemorrhagic lesions [lobar intracerebral macrohemorrhage, cortical microhemorrhage, and cortical superficial siderosis (cSS)/focal convexity subarachnoid hemorrhage (SAH)], ischemic lesions (cortical infarction and ischemic changes of the white matter), and encephalopathies that include subacute leukoencephalopathy caused by CAA-associated inflammation/angiitis. Thus, CAA is related to dementia, stroke, and encephalopathies. Recent advances in diagnostic procedures, particularly neuroimaging, have enabled us to establish a clinical diagnosis of CAA without brain biopsies. Sensitive magnetic resonance imaging (MRI) methods, such as gradient-echo T2* imaging and susceptibility-weighted imaging, are useful for detecting cortical microhemorrhages and cSS. Amyloid imaging with amyloid-binding positron emission tomography (PET) ligands, such as Pittsburgh Compound B, can detect CAA, although they cannot discriminate vascular from parenchymal amyloid deposits. In addition, cerebrospinal fluid markers may be useful, including levels of Aβ40 for CAA and anti-Aβ antibody for CAA-related inflammation. Moreover, cSS is closely associated with transient focal neurological episodes (TFNE). CAA-related inflammation/angiitis shares pathophysiology with amyloid-related imaging abnormalities (ARIA) induced by Aβ immunotherapies in AD patients. This article reviews CAA and CAA-related disorders with respect to their epidemiology, pathology, pathophysiology, clinical features, biomarkers, diagnosis, treatment, risk factors, and future perspectives.
Abstract
Cerebral amyloid angiopathy (CAA) involves cerebrovascular amyloid deposition and is classified into several types according to the amyloid protein involved. Of these, sporadic amyloid β-protein (Aβ)-type CAA is most commonly found in older individuals and in patients with Alzheimer’s disease (AD). Cerebrovascular Aβ deposits accompany functional and pathological changes in cerebral blood vessels (CAA-associated vasculopathies). CAA-associated vasculopathies lead to development of hemorrhagic lesions [lobar intracerebral macrohemorrhage, cortical microhemorrhage, and cortical superficial siderosis (cSS)/focal convexity subarachnoid hemorrhage (SAH)], ischemic lesions (cortical infarction and ischemic changes of the white matter), and encephalopathies that include subacute leukoencephalopathy caused by CAA-associated inflammation/angiitis. Thus, CAA is related to dementia, stroke, and encephalopathies. Recent advances in diagnostic procedures, particularly neuroimaging, have enabled us to establish a clinical diagnosis of CAA without brain biopsies. Sensitive magnetic resonance imaging (MRI) methods, such as gradient-echo T2* imaging and susceptibility-weighted imaging, are useful for detecting cortical microhemorrhages and cSS. Amyloid imaging with amyloid-binding positron emission tomography (PET) ligands, such as Pittsburgh Compound B, can detect CAA, although they cannot discriminate vascular from parenchymal amyloid deposits. In addition, cerebrospinal fluid markers may be useful, including levels of Aβ40 for CAA and anti-Aβ antibody for CAA-related inflammation. Moreover, cSS is closely associated with transient focal neurological episodes (TFNE). CAA-related inflammation/angiitis shares pathophysiology with amyloid-related imaging abnormalities (ARIA) induced by Aβ immunotherapies in AD patients. This article reviews CAA and CAA-related disorders with respect to their epidemiology, pathology, pathophysiology, clinical features, biomarkers, diagnosis, treatment, risk factors, and future perspectives.
참고문헌 (124)
- Scholz W., "Studien zur Pathologie der Hirngefäße II. Die drusige Entartung der Hirnarterien und Kapillaren", Z ges Neurol Psychiat, 162, pp.694~715 (1938)
- Surbek B, "L’angiopathie dyshorique (Morel) de l’écorce cérébrale", Acta Neuropathol, 1, pp.168~197 (1961)
- Pantelakis S., "Un type particulier d’angiopathie sénile du système nerveux central: l’angiopathice congophile. Topographie et fréquence", Mschr Psychiatr Neurol, 128, pp.219~256 (1954)
- Vinters HV., "Cerebral amyloid angiopathy. A critical review", Stroke, 18, pp.311~324 (1987)
- Yamada M, "Cerebral amyloid angiopathy", Prog Mol Biol Transl Sci, 51, pp.41~78 (2012)
- Yamada M, "Cerebral amyloid angiopathy in the aged", J Neurol, 234, pp.371~376 (1987)
- Masuda J, "Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan", Stroke, 19, pp.205~210 (1988)
- Yamada M, "Risk factors for cerebral amyloid angiopathy in the elderly", Ann N Y Acad Sci, 977, pp.37~44 (2002)
- Hirohata M, "Clinical features of non-hypertensive lobar intracerebral hemorrhage related to cerebral amyloid angiopathy", Eur J Neurol, 17, pp.823~829 (2010)
- Yamaguchi H, "Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer’s disease. An immunoelectron microscopic study", Am J Pathol, 141, pp.249~259 (1992)
- Thal DR, "Two types of sporadic cerebral amyloid angiopathy", J Neuropathol Exp Neurol, 61, pp.282~293 (2002)
- Mandybur TI, "Cerebral amyloid angiopathy : the vascular pathology and complications", J Neuropathol Exp Neurol, 45, pp.79~90 (1986)
- Vonsattel JP, "Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study", Ann Neurol, 30, pp.637~649 (1991)
- Maeda A, "Computer-assisted three-dimensional image analysis of cerebral amyloid angiopathy", Stroke, 24, pp.1857~1864 (1993)
- Prelli F, "Differences between vascular and plaque core amyloid in Alzheimer’s disease", J Neurochem, 51, pp.648~651 (1988)
- Suzuki N, "High tissue content of soluble β1-40 is linked to cerebral amyloid angiopathy", Am J Pathol, 145, pp.452~460 (1994)
- Weller RO, "Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer’s disease", Am J Pathol, 153, pp.725~733 (1998)
- Yamada M, "Predicting cerebral amyloid angiopathy-related intracerebral hemorrhages and other cerebrovascular disorders in Alzheimer’s disease", Front Neurol, 3, pp.64~ (2012)
- Samarasekera N, "The association between cerebral amyloid angiopathy and intracerebral haemorrhage: systematic review and meta-analysis", J Neurol Neurosurg Psychiatry, 83, pp.275~281 (2012)
- Meretoja A, "SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage", Stroke, 43, pp.2592~2597 (2012)
- Yeh SJ, "Pathogenetical subtypes of recurrent intracerebral hemorrhage: designations by SMASH-U classification system", Stroke, 45, pp.2636~2642 (2014)
- Béjot Y, "Intracerebral haemorrhage profiles are changing: results from the Dijon population-based study", Brain, 136, pp.658~664 (2013)
- Itoh Y, "Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly", J Neurol Sci, 116, pp.135~141 (1993)
- Yamada M, "Subarachnoid haemorrhage in the elderly: a necropsy study of the association with cerebral amyloid angiopathy", J Neurol Neurosurg Psychiatry, 56, pp.543~547 (1993)
- Ohshima T, "Cerebral amyloid angiopathy as a cause of subarachnoid hemorrhage", Stroke, 21, pp.480~483 (1990)
- Hanyu H, "Cerebral microbleeds in Alzheimer’s disease", J Neurol, 250, pp.1496~1497 (2003)
- Nakata-Kudo Y, "Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease", Dement Geriatr Cogn Disord, 22, pp.8~14 (2006)
- Cordonnier C, "Prevalence and severity of microbleeds in a memory clinic setting", Neurology, 66, pp.1356~1360 (2006)
- Cordonnier C, "Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting", Brain, 130, pp.1988~2003 (2007)
- Pettersen JA, "Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study", Arch Neurol, 65, pp.790~795 (2008)
- Brundel M, "High prevalence of cerebral microbleeds at 7Tesla MRI in patients with early Alzheimer’s disease", J Alzheimers Dis, 31, pp.259~263 (2012)
- Linn J, "Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy", Neurology, 74, pp.1346~1350 (2010)
- Yates PA, "Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease", Neurology, 77, pp.48~54 (2011)
- Dierksen GA, "Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy", Ann Neurol, 68, pp.545~548 (2010)
- Gurol ME, "Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy", Neurology, 79, pp.320~326 (2012)
- van Etten ES, "Incidence of symptomatic hemorrhage in patients with lobar microbleeds", Stroke, 45, pp.2280~2285 (2014)
- Feldman HH, "Superficial siderosis: a potential diagnostic marker of cerebral amyloid angiopathy in Alzheimer disease", Stroke, 39, pp.2894~2897 (2008)
- Kumar S, "Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies", Neurology, 74, pp.893~899 (2010)
- Vernooij MW, "Superficial siderosis in the general population", Neurology, 73, pp.202~205 (2009)
- Charidimou A, "Cortical superficial siderosis and intracerebral hemorrhage risk in cerebral amyloid angiopathy", Neurology, 81, pp.1666~1673 (2013)
- Shoamanesh A, "Interrelationship of superficial siderosis and microbleeds in cerebral amyloid angiopathy", Neurology, 83, pp.1838~1843 (2014)
- Linn J, "Superficial siderosis is a warning sign for future intracranial hemorrhage", J Neurol, 260, pp.176~181 (2013)
- Wollenweber FA, "Prevalence of cortical superficial siderosis in patients with cognitive impairment", J Neurol, 261, pp.277~282 (2014)
- Zonneveld HI, "Prevalence of cortical superficial siderosis in a memory clinic population", Neurology, 82, pp.698~704 (2014)
- Izenberg A, "Crescendo transient aura attacks: a transient ischemic attack mimic caused by focal subarachnoid hemorrhage", Stroke, 40, pp.3725~3729 (2009)
- Beitzke M, "Clinical presentation, etiology, and long-term prognosis in patients with nontraumatic convexal subarachnoid hemorrhage", Stroke, 42, pp.3055~3060 (2011)
- Charidimou A, "Spectrum of transient focal neurological episodes in cerebral amyloid angiopathy : multicentre magnetic resonance imaging cohort study and meta-analysis", Stroke, 43, pp.2324~2330 (2012)
- Apoil M, "Focal cortical subarachnoid hemorrhage revealed by recurrent paresthesias: a clinico-radiological syndrome strongly associated with cerebral amyloid angiopathy", Cerebrovasc Dis, 36, pp.139~144 (2013)
- Charidimou A, "Transient focal neurological episodes, cerebral amyloid angiopathy, and intracerebral hemorrhage risk: looking beyond TIAs", Int J Stroke, 8, pp.105~108 (2013)
- Zhu YC, "Distribution of white matter hyperintensity in cerebral hemorrhage and healthy aging", J Neurol, 259, pp.530~536 (2012)
- Thanprasertsuk S, "Posterior white matter disease distribution as a predictor of amyloid angiopathy", Neurology, 83, pp.794~800 (2014)
- Gurol ME, "Cerebral amyloid angiopathy burden associated with leukoaraiosis : a positron emission tomography", magnetic resonance imaging study, 2013, pp.73, 529~536
- Kimberly WT, "Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy", Neurology, 72, pp.1230~1235 (2009)
- Gregoire SM, "Acute ischaemic brain lesions in intracerebral haemorrhage: multicentre cross-sectional magnetic resonance imaging study", Brain, 134, pp.2376~2386 (2011)
- Vallat W, "Cerebral amyloid angiopathy causing cortical microinfarction", J Clin Neurosci, 20, pp.1802~1804 (2013)
- Yamada M, "Vascular variant of Alzheimer’s disease characterized by severe plaque-like beta protein angiopathy", Dement Geriatr Cogn Disord, 8, pp.163~168 (1997)
- Cordonnier C, "What are the causes of pre-existing dementia in patients with intracerebral haemorrhages?", Brain, 133, pp.3281~3289 (2010)
- Arvanitakis Z, "Cerebral amyloid angiopathy pathology and cognitive domains in older persons", Ann Neurol, 69, pp.320~327 (2011)
- Yamada M, "Immune reactions associated with cerebral amyloid angiopathy", Stroke, 27, pp.1155~1162 (1996)
- Oh U, "Reversible leukoencephalopathy associated with cerebral amyloid angiopathy", Neurology, 62, pp.494~497 (2004)
- Eng JA, "Clinical manifestations of cerebral amyloid angiopathy-related inflammation", Ann Neurol, 55, pp.250~256 (2004)
- Scolding NJ, "Aβ-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy", Brain, 128, pp.500~515 (2005)
- Kinnecom C, "Course of cerebral amyloid angiopathy-related inflammation", Neurology, 68, pp.1411~1416 (2007)
- DiFrancesco JC, "Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report", Neurology, 76, pp.842~844 (2011)
- Piazza F, "Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies", Ann Neurol, 73, pp.449~458 (2013)
- Nandigam RN, "MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength", AJNR Am J Neuroradiol, 30, pp.338~343 (2009)
- Ii Y, "In vivo detection of cortical microinfarcts on ultrahigh-field MRI", J Neuroimaging, 23, pp.28~32 (2013)
- Radmanesh F, "Risk factors for computed tomography angiography spot sign in deep and lobar intracerebral hemorrhage are shared", Stroke, 45, pp.1833~1835 (2014)
- Charidimou A, "Enlarged perivascular spaces as a marker of underlying arteriopathy in intracerebral haemorrhage : a multicentre MRI cohort study", J Neurol Neurosurg Psychiatry, 84, pp.624~629 (2013)
- Charidimou A, "White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy?", Neurology, 82, pp.57~62 (2014)
- Charidimou A, "White matter perivascular spaces are related to cortical superficial siderosis in cerebral amyloid angiopathy", Stroke, 45, pp.2930~2935 (2014)
- Smith EE, "Impaired visual evoked flow velocity response in cerebral amyloid angiopathy", Neurology, 71, pp.1424~1430 (2008)
- Dumas A, "Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy", Ann Neurol, 72, pp.76~81 (2012)
- Peca S, "Neurovascular decoupling is associated with severity of cerebral amyloid angiopathy", Neurology, 81, pp.1659~1665 (2013)
- Johnson KA, "Imaging of amyloid burden and distribution in cerebral amyloid angiopathy", Ann Neurol, 62, pp.229~234 (2007)
- Bacskai BJ, "Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report", Arch Neurol, 64, pp.431~434 (2007)
- Ly JV, "11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage", Neurology, 74, pp.487~493 (2010)
- Baron JC, "Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage", J Cereb Blood Flow Metab, 34, pp.753~758 (2014)
- Rutgers KS, "Differential recognition of vascular and parenchymal beta amyloid deposition", Neurobiol Aging, 32, pp.1774~1783 (2011)
- Verbeek MM, "Cerebrospinal fluid amyloid β40 is decreased in cerebral amyloid angiopathy", Ann Neurol, 66, pp.245~249 (2009)
- Renard D, "Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria", J Neurol, 259, pp.2429~2433 (2012)
- Hernandez-Guillamon M, "Plasma β-amyloid levels in cerebral amyloid angiopathy-associated hemorrhagic stroke", Neurodegener Dis, 10, pp.320~323 (2012)
- Knudsen KA, "Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria", Neurology, 56, pp.537~539 (2001)
- Greene GM, "Surgical experience with cerebral amyloid angiopathy", Stroke, 21, pp.1545~1549 (1990)
- Greenberg SM, "Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy", Ann Neurol, 38, pp.254~259 (1995)
- Premkumar DR, "Apolipoprotein E-ε4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer’s disease", Am J Pathol, 148, pp.2083~2095 (1996)
- Nicoll JA, "High frequency of apolipoprotein E ε2 allele in hemorrhage due to cerebral amyloid angiopathy", Ann Neurol, 41, pp.716~721 (1997)
- Brouwers HB, "Apolipoprotein E genotype is associated with CT angiography spot sign in lobar intracerebral hemorrhage", Stroke, 43, pp.2120~2125 (2012)
- O’Donnell HC, "Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage", N Engl J Med, 342, pp.240~245 (2000)
- Maxwell SS, "Genetic associations with brain microbleeds: systematic review and meta-analyses", Neurology, 77, pp.158~167 (2011)
- Leclercq PD, "Cerebral amyloid angiopathy in traumatic brain injury: association with apolipoprotein E genotype", J Neurol Neurosurg Psychiatry, 76, pp.229~233 (2005)
- Hamaguchi T, "Association of a polymorphism of the transforming growth factor-β1 gene with cerebral amyloid angiopathy", J Neurol Neurosurg Psychiatry, 76, pp.696~699 (2005)
- Peila R, "A TGF-β1 polymorphism association with dementia and neuropathologies: the HAAS", Neurobiol Aging, 28, pp.1367~1373 (2007)
- Yamada M, "Cerebral amyloid angiopathy and gene polymorphisms", J Neurol Sci, 226, pp.41~44 (2004)
- Yamada M, "Association of presenilin-1 polymorphism with cerebral amyloid angiopathy in the elderly", Stroke, 28, pp.2219~2221 (1997)
- Yamada M, "Association of α1-antichymotrypsin polymorphism with cerebral amyloid angiopathy", Ann Neurol, 44, pp.129~131 (1998)
- Yamada M, "Association of neprilysin polymorphism with cerebral amyloid angiopathy", J Neurol Neurosurg Psychiatry, 74, pp.749~751 (2003)
- Christoforidis M, "Genetic-morphologic association study: association between the low density lipoprotein-receptor related protein (LRP) and cerebral amyloid angiopathy", Neuropathol Appl Neurobiol, 31, pp.11~19 (2005)
- Domingues-Montanari S, "ACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathy", Neurobiol Aging, 32, pp.551~ (2011)
- Thal DR, "Capillary cerebral amyloid angiopathy identifies a distinct APOE ε4-associated subtype of sporadic Alzheimer’s disease", Acta Neuropathol, 120, pp.169~183 (2010)
- Biffi A, "Genetic variation at CR1 increases risk of cerebral amyloid angiopathy", Neurology, 78, pp.334~341 (2012)
- Arima H, "Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial", Stroke, 41, pp.394~396 (2010)
- Rosand J, "Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study", Neurology, 55, pp.947~951 (2000)
- McCarron MO, "Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage", Lancet Neurol, 3, pp.484~492 (2004)
- Charidimou A, "Cerebral microbleeds and the risk of intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: systematic review and meta-analysis", J Neurol Neurosurg Psychiatry, 84, pp.277~280 (2013)
- Charidimou A, "Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk", Front Neurol, 3, pp.133~ (2012)
- Falcone GJ, "APOE ε variants increase risk of warfarin-related intracerebral hemorrhage", Neurology, 83, pp.1139~1146 (2014)
- Vernooij MW, "Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study", Arch Neurol, 66, pp.714~720 (2009)
- Thoonsen H, "Aspirin in Alzheimer’s disease: increased risk of intracerebral hemorrhage: cause for concern?", Stroke, 41, pp.2690~2692 (2010)
- Boche D, "Consequence of Aβ immunization on the vasculature of human Alzheimer’s disease brain", Brain, 131, pp.3299~3310 (2008)
- Orgogozo JM, "Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization", Neurology, 61, pp.46~54 (2003)
- Nicoll JA, "Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report", Nat Med, 9, pp.448~452 (2003)
- Sperling R, "Amyloid-related imaging abnormalities in patients with Alzheimer’s disease treated with bapineuzumab: a retrospective analysis", Lancet Neurol, 11, pp.241~249 (2012)
- Carlson C, "Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer’s disease study cohorts from phase 3 trials of semagacestat and solanezumab", Alzheimers Dement, 7, pp.396~401 (2011)
- La Porte SL, "Structural basis of C-terminal β-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer’s disease", J Mol Biol, 421, pp.525~536 (2012)
- Miyoshi I, "Safety and pharmacokinetics of PF-04360365 following a single-dose intravenous infusion in Japanese subjects with mild-to-moderate Alzheimer’s disease: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation study", Int J Clin Pharmacol Ther, 51, pp.911~923 (2013)
- Burstein AH, "Safety and pharmacology of ponezumab (PF-04360365) after a single 10-minute intravenous infusion in subjects with mild to moderate Alzheimer disease", Clin Neuropharmacol, 36, pp.8~13 (2013)
- Landen JW, "Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study", Clin Neuropharmacol, 36, pp.14~23 (2013)
- "ClinicalTrials.gov"[URL]
- Revesz T, "Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies", Acta Neuropathol, 118, pp.115~130 (2009)
- Hernandez-Guillamon M, "MMP-2", MMP-9 plasma level and brain expression in cerebral amyloid angiopathy-associated hemorrhagic stroke, 2012, pp.22, 133~141
- Lee JM, "Matrix metalloproteinase-9 in cerebral-amyloid-angiopathy-related hemorrhage", J Neurol Sci, 229-230, pp.249~254 (2005)
- McCarron MO, "The apolipoprotein E ε2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage", J Neuropathol Exp Neurol, 58, pp.711~718 (1999)
- Biffi A, "APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study", Lancet Neurol, 10, pp.702~709 (2011)
